Keep up with

HHO News

Category filter:AllAnnouncementsCancer TreatmentEducationalEventsLifestylePressPreventionSuccess Stories
No more posts


November 5, 2022 Press

At Hunterdon Hematology Oncology (HHO), our team consistently strives to set new standards in cancer care. We are thrilled to celebrate the outstanding recognition of our physicians—Drs. Kenneth Blankstein, Myron Bednar, Megha Shah, Waqas Rehman, and Swee Ngeow—as NJ Top Docs for 2023.

Located in Flemington, NJ, within the Hunterdon Regional Cancer Center, our specialists offer cutting-edge treatments, personalized care, and comprehensive patient support. Their recognition as NJ Top Docs highlights our physicians’ exceptional commitment to clinical excellence and patient-centered care.

Learn more about these remarkable doctors and their approaches to advanced oncology care:

Check out the NJ Top Docs feature for Hunterdon Hematology Oncology in the current issue of Healthy Living Magazine

 



October 15, 2022 Press

Hunterdon Hematology Oncology is honored to announce that our dedicated physicians, Dr. Kenneth Blankstein and Dr. Myron Bednar, have been recognized as Jersey Choice Top Doctors for 2022 by New Jersey Monthly Magazine.

What makes this award so meaningful?

It means that among thousands of New Jersey doctors, Drs. Blankstein and Bednar have earned the respect and trust of their colleagues, who selected them as physicians they would choose to care for their own loved ones. This prestigious acknowledgment underscores their exceptional skill, compassionate care, and dedication to patient well-being.

Choosing Hunterdon Hematology Oncology means choosing doctors who continually strive for excellence and innovation, bringing world-class cancer care right to your community.

Congratulations again to Dr. Blankstein and Dr. Bednar—we celebrate your continued commitment to exceptional patient care!

   

 



November 5, 2021 Press

At Hunterdon Hematology Oncology (HHO), we are proud to celebrate the accomplishments of our exceptional physicians—Drs. Myron Bednar, Kenneth B. Blankstein, and Swee Ngeow—who have earned recognition as NJ Top Docs for 2022.

Our award-winning specialists are known for their dedication to providing personalized and innovative cancer treatments in a compassionate environment. Situated within the Hunterdon Regional Cancer Center in Flemington, NJ, HHO delivers advanced therapies and cutting-edge clinical research directly to our community.

Learn more about our recognized team of oncology experts:

Check out the NJ Top Docs feature for Hunterdon Hematology Oncology in the current issue of Healthy Living Magazine

 



November 15, 2020 Press

Exceptional care comes from exceptional physicians. Hunterdon Hematology Oncology is proud to share that our own Dr. Kenneth Blankstein and Dr. Myron Bednar have been named Jersey Choice Top Doctors for 2020 by New Jersey Monthly Magazine, affirming their unwavering dedication to excellence in oncology and patient well-being.

Being selected as a Jersey Choice Top Doctor is no ordinary honor. It means these physicians are not only recognized by their peers for their clinical skills but are also admired for their heartfelt commitment to their patients and their community. Read more about their unique approach to patient care in the latest issue of New Jersey Monthly magazine highlighting the Top Doctors for 2020.

At Hunterdon Hematology Oncology, we strive daily to ensure that each patient receives personalized, advanced care from physicians who set the benchmark for medical excellence. Drs. Blankstein and Bednar exemplify this standard, consistently delivering innovative treatments and compassionate care.

We are inspired by their achievements and honored to have them lead our mission to conquer cancer together.

Join us in celebrating their outstanding recognition!

.   

 



November 5, 2020 Press

Hunterdon Hematology Oncology (HHO) is excited to honor three of our exceptional physicians—Drs. Myron Bednar, Kenneth B. Blankstein, and Swee Ngeow—who have been recognized as NJ Top Docs for 2021.

Our renowned oncology experts at HHO consistently deliver advanced, personalized cancer treatments with compassion and care. Conveniently located within the Hunterdon Regional Cancer Center in Flemington, NJ, our team provides leading-edge therapies, groundbreaking clinical trials, and comprehensive patient support services.

Discover more about our recognized oncology specialists:

Check out the NJ Top Docs feature for Hunterdon Hematology Oncology in the current issue of Healthy Living Magazine

 



October 15, 2020 Press

At Hunterdon Hematology Oncology, our mission is simple yet powerful: to bring world-class cancer treatment directly to our community of hunterdon county. Today, we’re proud to announce that two of our dedicated physicians, Dr. Kenneth Blankstein and Dr. Myron Bednar, have been honored as Jersey Choice Top Doctors for 2020 by New Jersey Monthly Magazine.

Why does this matter to you?

This prestigious distinction means that Drs. Blankstein and Bednar have been recognized by their fellow physicians as leading experts trusted to care for their own family members. The selection involves nominations from over 20,000 practicing physicians across New Jersey, followed by a thorough review by an advisory board of previous award winners.

When you choose Hunterdon Hematology Oncology, you’re not just getting advanced treatments; you’re being cared for by physicians nationally recognized for their medical expertise, compassion, and dedication to excellence.

Join us in congratulating Dr. Blankstein and Dr. Bednar. Together, we continue our commitment to exceptional cancer care close to home.

       

 


BlogImage_27.png

June 23, 2020 Press

Congratulations Dr. Shah! We are excited to announce that our very own, Dr. Megha Shah, has been published in the Journal Of Endocrine Health. This article contains information regarding the SAT-358 Hypercalcemia-Induced Altered Mental Status as the Primary Manifestation of Classic Hodgkin Lymphoma. If you are interested in learning more, read the article here.


BlogImage_11.jpeg

May 21, 2019 Press

Providing the highest-quality cancer care in a compassionate manner is a top priority of Dr. Myron Bednar. Board certified in medical oncology, hematology and internal medicine, he actively participates in cancer research trials and is committed to bringing patients new and innovative investigational treatments. Dr. Bednar is currently excited to participate in MATCH, a national clinical study in which cancer-fighting drugs are assigned based on the specific mutations present in a patient’s tumors.

He offers a variety of options on-site, from radiation to infusion-based and oral chemotherapy, as well as immune-based therapy, which stimulates a patient’s immune system to attack cancer cells. Read more.


BlogImage_7.jpeg

May 21, 2019 Press

Dr. Kenneth B. Blankstein, an oncologist in Flemington, N.J., is treating a woman for lung cancer. She responded well to the first chemotherapy drugs he prescribed. When her health was stable, he gave her a “temporary break” from chemo to spare her some of its side effects.

But when he tried to return her to the treatment, the insurer balked, saying that the “temporary break” was evidence that the treatment had failed. Despite Blankstein’s protests, the insurer said she would have to move next to Tarceva, another treatment.

“She had under a 5 percent chance of a response on Tarceva,” he said. “Yet they insisted, so we had to.”

As Blankstein expected, the patient did not respond, but instead of letting her return to the first chemo cocktail, the insurer insisted she try another drug first.

The patient ultimately switched to Medicare, which covered the first chemotherapy protocol. Her health is stable.

“The patient’s being told to use a drug we know isn’t going to work, but we have to use it anyway for someone with terminal illness? To me that’s just insane, but it’s the way they do things,” Blankstein said. “It’s taken away clinical judgment. It’s managing by algorithms.” Read the whole article.



November 5, 2018 Press

Hunterdon Hematology Oncology (HHO) is delighted to announce that our very own Dr. Swee Ngeow has earned recognition as an NJ Top Doc for 2019. This esteemed acknowledgment reflects Dr. Ngeow‘s unwavering commitment to delivering personalized and advanced cancer care to patients in Hunterdon County and beyond.

Situated at the Hunterdon Regional Cancer Center, Dr. Ngeow is renowned for her expertise in oncology treatments, dedication to clinical research, and compassionate patient care. Her recognition as an NJ Top Doc underscores her exceptional contributions to the field of oncology.

Learn more about Dr. Ngeow’s exceptional approach to oncology care here.

Check out the NJ Top Docs feature for Hunterdon Hematology Oncology in the current issue of Healthy Living Magazine

 




About HHO


Hunterdon Hematology Oncology is a community oncology group, dedicated to fighting cancer in this community and across the region. Our Doctors, Physician’s Assistants and Nurses work tirelessly. They fight hard so that you can win.




Subscribe


Sign up for the HHO newsletter to stay up to date on the latest news within the practice and the community.



    © HHO 2022. All rights reserved. Designed by DRAW